TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX)

Historical Holders from Q1 2024 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
TENX on Nasdaq
Shares outstanding
6,273,457
Price per share
$9.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
4,720,738
Total reported value
$35,929,590
% of total 13F portfolios
0%
Share change
+2,488,777
Value change
+$18,970,343
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
34
Price from insider filings
$10.22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vestal Point Capital, LP 9.9% $18,525,720 2,470,096 Vestal Point Capital, LP 30 Sep 2024
Ikarian Capital, LLC 16% -27% $6,473,244 967,600 0% Ikarian Capital, LLC 30 Nov 2025
JANUS HENDERSON GROUP PLC 10% +150% $4,172,774 +$3,057,778 623,733 +274% JANUS HENDERSON GROUP PLC 28 Nov 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% $4,147,275 552,970 Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
Lind Global Fund II LP 8.8% $3,318,600 442,480 Lind Global Fund II LP 30 Sep 2025
PERCEPTIVE ADVISORS LLC 7% $4,158,675 439,142 Perceptive Advisors LLC 18 Dec 2025
Invus Global Management, LLC 9.4% $2,562,846 427,141 Raymond Debbane 26 Sep 2025
RTW INVESTMENTS, LP 10% $2,460,427 418,440 RTW Investments, LP 31 Mar 2025
Dellora Investments LP 8.8% -15% $2,064,297 +$739,528 351,071 0% Dellora Investments LP 05 Mar 2025
Point72 Asset Management, L.P. 7.4% $2,037,798 339,633 Point72 Asset Management, L.P. 22 Oct 2025
INTEGRATED CORE STRATEGIES (US) LLC 6.9% +22% $1,882,272 +$480,576 313,712 +34% Integrated Core Strategies (US) LLC 30 Sep 2025
S.H.N. Financial Investments Ltd. 5% $1,052,814 179,050 S.H.N. Financial Investments Ltd. 31 Dec 2024
As of 30 Sep 2025, TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) has 34 institutional shareholders filing 13F forms. They hold 4,720,738 shares. of 6,273,457 outstanding shares (75%) .

Top 25 institutional shareholders own 75% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Ikarian Capital, LLC 15% 967,600 1.7% $7,363,436
VR ADVISER, LLC 7% 437,708 +344% 0.19% $3,330,958
RTW INVESTMENTS, LP 6% 378,346 0% 0.04% $2,879,213
Siren, L.L.C. 5.6% 352,441 0.1% $2,682,076
BOOTHBAY FUND MANAGEMENT, LLC 5.6% 352,206 0.07% $2,680,288
BVF INC/IL 5.4% 339,549 0% 0.1% $2,583,968
MILLENNIUM MANAGEMENT LLC 5% 313,712 +34% 0% $2,387,348
Vivo Capital, LLC 3.3% 208,333 0% 0.13% $1,585,414
MORGAN STANLEY 2.8% 178,329 +0.18% 0% $1,357,084
MARSHALL WACE, LLP 2.8% 177,209 0% $1,348,560
Integral Health Asset Management, LLC 2.7% 167,000 0% 0.09% $1,270,870
JANUS HENDERSON GROUP PLC 2.7% 166,666 0% 0% $1,273,328
VANGUARD GROUP INC 2.6% 161,800 +626% 0% $1,231,298
Woodline Partners LP 1.4% 88,211 0% $671,286
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.3% 83,333 0% 0% $634,164
Velan Capital Investment Management LP 1.3% 83,333 0% 0.6% $634,164
RENAISSANCE TECHNOLOGIES LLC 0.9% 56,600 0% $430,726
Vestal Point Capital, LP 0.85% 53,439 0% 0.02% $406,671
ADAR1 Capital Management, LLC 0.85% 53,428 -66% 0.04% $406,587
CITADEL ADVISORS LLC 0.69% 43,253 +318% 0% $329,156
GEODE CAPITAL MANAGEMENT, LLC 0.55% 34,425 +0.55% 0% $261,974
Virtu Financial LLC 0.19% 12,119 0.01% $92,000
DRW Securities, LLC 0.17% 10,514 0% $80,011
Tower Research Capital LLC (TRC) 0.01% 501 -60% 0% $3,813
BlackRock, Inc. 0% 301 +0.33% 0% $2,291

Institutional Holders of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 1 $9 900% 1
2025 Q3 4,720,738 $35,929,590 +$18,970,343 761% 34
2025 Q2 2,231,961 $12,926,914 +$1,314,380 576% 25
2025 Q1 2,006,422 $13,111,231 +$4,224,591 655% 23
2024 Q4 1,362,190 $8,426,122 +$1,144,778 619% 21
2024 Q3 1,228,920 $4,253,022 +$4,189,827 346% 19
2024 Q2 18,829 $57,207 +$35,228 301.5% 10
2024 Q1 7,235 $30,532 +$30,532 423.99% 9